Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Nakamoto Inc.NASDAQ: NAKA

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 15.91M shares rose 160.6% year over year, ahead of the +89.0% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 40.0% from the prior quarter. Over 3 fiscal years it compounded at +24.5% a year.

Context

  • Weighted avg shares increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +160.6% holds above the trailing-twelve-month pace of +89.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
15.91M+40.0% QoQ
Last fiscal yearDec 2025
11.36M+110.8% YoY
LTMMar 2026
11.36M+89.0% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+160.6%——
1 year+110.8%——
3-year CAGR+24.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
11.36M USD
Year-over-year change
+110.8%
4-year CAGR
+17.5%

Weighted Avg Shares vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 weighted avg shares of 11.36M shares is the lowest of the 11 companies compared; the peer median is 52.39M shares.
  • Its year-over-year change of +89.0% is the highest of 11, against a peer median of +1.9%.
  • Over three fiscal years its annual growth of +24.5% compares with a peer median of +2.8%.
NAKA Competitors Peer median
Weighted Avg Shares for NAKA and competitors
Company Period LTM YoY 3-year CAGR
DHDefinitive Healthcare Corp.LTM Mar 2026104.66M -9.4%+1.8%
CLLSCellectis S.A.LTM Mar 2026100.38M +2.9%+30.1%
DBVTDBV Technologies S.A.LTM Mar 202688.66M -7.8%+3.7%
LRMRLarimar Therapeutics, Inc.LTM Mar 202678.18M +22.5%+41.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 202668.62M +3.6%+1.8%
DCTHDelcath Systems, Inc.LTM Mar 202636.16M +16.9%+59.3%
AMRNAmarin Corporation plcLTM Mar 202620.78M +1.0%+1.1%
SLPSimulations Plus, Inc.LTM Feb 202620.14M +0.4%-0.2%
LYELLyell Immunopharma, Inc.LTM Mar 202618.01M +34.2%+11.4%
AGLAgilon Health, Inc.LTM Mar 202616.58M +0.6%+0.5%
NAKANakamoto Inc.LTM Mar 202611.36M +89.0%+24.5%
Peer median (excluding NAKA) 52.39M+1.9%+2.8%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.5M3.79M3.77M2.72M1.82M
Cost of Revenue1.59M152.39K226.17K3.56M11.09M
Gross Profit914.92K3.63M3.54M(842.57K)(9.27M)
Gross Margin36.5%96.0%94.0%-31.0%-508.8%
Research & Development002.5K377.73K0
Selling, General & Admin853.58K6.27M5.05M1.91M11.76M
Operating Expenses853.58K6.33M5.16M2.5M187.87M
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
EBITDA124.74K(2.42M)(1.36M)(3M)(44.93M)
EBITDA Margin5.0%-63.9%-36.0%-110.4%-2466.7%
Operating Income61.34K(2.69M)(1.62M)(3.35M)(197.14M)
Operating Margin2.4%-71.1%-43.0%-123.1%-10824.0%
Interest Income00000
Interest Expense0055.84K393.45K7.06M
Other Income / Expenses88K152.82K2.76K(270.88K)144.91M
Income Before Tax149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Pre-Tax Margin6.0%-67.1%-42.9%-133.0%-2867.6%
Income Tax Expense00000
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Net Margin6.0%-67.1%-42.9%-133.0%-2867.6%
EPS (Basic)0.03(0.43)(0.27)(0.67)(10.40)
EPS (Diluted)0.03(0.43)(0.27)(0.67)(10.40)
Weighted Avg Shares5.97M5.89M5.89M5.39M11.36M
Weighted Avg Shares (Diluted)5.97M5.89M5.89M5.39M11.36M

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.